Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 18657294)

Published in Hum Pathol on July 26, 2008

Authors

Svetlana Savin1, Dubravka Cvejic, Tijana Isic, Ivan Paunovic, Svetislav Tatic, Marija Havelka

Author Affiliations

1: Institute for the Application of Nuclear Energy-INEP, University of Belgrade, Zemun-Belgrade, Serbia. ssavin@inep.co.yu

Articles by these authors

Adrenalectomy for solid tumor metastases: results of a multicenter European study. Surgery (2013) 1.71

Parathyroidectomy for the attainment of NKF-K/DOQI™ and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism. Langenbecks Arch Surg (2012) 1.02

Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors. APMIS (2011) 0.95

Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg (2013) 0.94

The impact of PTEN tumor suppressor gene on acquiring resistance to tamoxifen treatment in breast cancer patients. Cancer Biol Ther (2012) 0.89

Case-control study of anaplastic thyroid cancer. Tumori (2004) 0.84

Apoptosis and proliferation related molecules (Bcl-2, Bax, p53, PCNA) in papillary microcarcinoma versus papillary carcinoma of the thyroid. Pathology (2008) 0.83

Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors. J Cancer Res Clin Oncol (2010) 0.82

Glucocorticoid receptor and molecular chaperones in the pathogenesis of adrenal incidentalomas: potential role of reduced sensitivity to glucocorticoids. Mol Med (2013) 0.82

Cytokeratin19 expression discriminates papillary thyroid carcinoma from other thyroid lesions and predicts its aggressive behavior. Med Oncol (2012) 0.81

Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration. Croat Med J (2014) 0.81

Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance. Wien Klin Wochenschr (2014) 0.80

Thyroid peroxidase immunohistochemistry in differential diagnosis of thyroid tumors. Endocr Pathol (2006) 0.80

Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO. Qual Life Res (2014) 0.80

Risk factors for well-differentiated thyroid cancer in men. Tumori (2013) 0.79

Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients. J Clin Lab Anal (2009) 0.79

Cigarette smoking as a risk factor for cancer of the thyroid in women. Tumori (2004) 0.78

[Pheochromocytoma--pathohistologic and immunohistochemical aspects]. Srp Arh Celok Lek (2002) 0.77

Risk factors for intraoperative hypotension during thyroid surgery. Med Sci Monit (2013) 0.76

Comparative analysis of collagenase XI and liberase H1 for the isolation of human pancreatic islets. Hepatogastroenterology (2011) 0.75

Pitfalls in diagnosing a small cystic insulinoma: a case report. J Med Case Rep (2007) 0.75

A case-control study of papillary thyroid cancer in children and adolescents. Eur J Cancer Prev (2013) 0.75

[Results of surgical treatment of pheochromocytoma at the Institute of Endocrinology of the Clinical Center of Serbia in Belgrade]. Srp Arh Celok Lek (2002) 0.75

Parathyroid cancer in a hemodialysis patient: a case report. Tumori (2002) 0.75

Giant pseudoaneurysm from Vieussens' arterial ring. Ann Thorac Surg (2004) 0.75

Intracardiac thrombosis and fever possibly triggered by ovulation induction in a patient with antiphospholipid antibodies. Scand J Rheumatol (2002) 0.75

Ten years' experience in subtotal parathyroidectomy of hemodialysis patients. Ren Fail (2005) 0.75

The relationship between proliferation activity and parathyroid hormone levels in parathyroid tumors. J BUON (2015) 0.75